Sylvamo (SLVM) Financials

Sylvamo logo
$36.31 -0.70 (-1.89%)
Closing price 11/19/2026 03:59 PM Eastern
Extended Trading
$36.35 +0.04 (+0.11%)
As of 11/19/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Sylvamo

Annual Income Statements for Sylvamo

This table shows Sylvamo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
377 170 331 118 253 302 132
Consolidated Net Income / (Loss)
377 170 331 118 253 302 132
Net Income / (Loss) Continuing Operations
377 87 227 336 253 302 132
Total Pre-Tax Income
502 95 328 467 369 405 199
Total Operating Income
493 91 327 536 403 444 238
Total Gross Profit
1,379 456 685 1,009 912 940 735
Total Revenue
4,017 2,385 2,828 3,628 3,721 3,773 3,351
Operating Revenue
4,017 2,385 2,828 3,628 3,721 3,773 3,351
Total Cost of Revenue
2,638 1,929 2,143 2,619 2,809 2,833 2,616
Operating Cost of Revenue
2,638 1,929 2,143 2,619 2,809 2,833 2,616
Total Operating Expenses
886 365 358 473 509 496 497
Selling, General & Admin Expense
655 202 207 325 343 311 281
Depreciation Expense
192 135 126 125 143 159 179
Other Operating Expenses / (Income)
33 28 25 23 23 26 26
Impairment Charge
- - - - 0.00 0.00 11
Total Other Income / (Expense), net
9.00 4.00 1.00 -69 -34 -39 -39
Interest Expense
-9.00 -4.00 -1.00 69 34 39 39
Income Tax Expense
125 8.00 101 131 116 103 67
Basic Earnings per Share
$8.55 $3.85 $7.53 $2.68 $6.02 $7.35 $3.29
Weighted Average Basic Shares Outstanding
- - 43.96M 42.37M 41.22M 40.55M 39.51M
Diluted Earnings per Share
$8.55 $3.85 $7.53 $2.66 $5.93 $7.18 $3.24
Weighted Average Diluted Shares Outstanding
- - 43.96M 42.37M 41.22M 40.55M 39.51M
Weighted Average Basic & Diluted Shares Outstanding
- - 43.96M 42.37M 41.22M 40.55M 39.51M
Cash Dividends to Common per Share
- - - $0.48 $1.40 $1.65 $1.80

Quarterly Income Statements for Sylvamo

This table shows Sylvamo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
43 83 95 81 27 15 57 33 -3.00 -11 -199
Consolidated Net Income / (Loss)
43 83 95 81 27 15 57 33 -3.00 -11 -199
Net Income / (Loss) Continuing Operations
43 83 95 81 27 15 71 33 -3.00 -11 85
Total Pre-Tax Income
60 113 132 100 33 20 105 58 -6.00 1.00 71
Total Operating Income
69 122 146 107 42 30 112 69 3.00 12 82
Total Gross Profit
189 249 265 237 159 154 219 200 125 132 205
Total Revenue
905 933 965 970 821 794 662 890 755 806 645
Operating Revenue
905 933 965 970 821 794 662 890 755 806 645
Total Cost of Revenue
716 684 700 733 662 640 443 690 630 674 440
Operating Cost of Revenue
716 684 700 733 662 640 443 690 630 674 440
Total Operating Expenses
120 127 119 130 117 124 107 131 122 120 123
Selling, General & Admin Expense
74 82 74 81 73 72 61 68 73 69 82
Depreciation Expense
39 37 39 44 40 45 41 45 41 43 36
Other Operating Expenses / (Income)
7.00 8.00 6.00 5.00 4.00 7.00 5.00 7.00 8.00 8.00 5.00
Total Other Income / (Expense), net
-9.00 -9.00 -14 -7.00 -9.00 -10 -7.00 -11 -9.00 -11 -11
Interest Expense
9.00 9.00 14 7.00 9.00 10 7.00 11 9.00 11 11
Income Tax Expense
17 30 37 19 6.00 5.00 34 25 -3.00 12 -14
Net Income / (Loss) Discontinued Operations
- - - - - - -14 - - - -284
Basic Earnings per Share
$1.04 $2.02 $2.32 $1.97 $0.66 $0.37 $1.43 $0.83 ($0.08) ($0.28) ($5.00)
Weighted Average Basic Shares Outstanding
41.13M 41.00M 41.01M 40.55M 40.72M 40.37M 39.44M 39.51M 39.74M 39.76M 39.77M
Diluted Earnings per Share
$1.02 $1.98 $2.27 $1.91 $0.65 $0.37 $1.41 $0.81 ($0.08) ($0.28) ($4.98)
Weighted Average Diluted Shares Outstanding
41.13M 41.00M 41.01M 40.55M 40.72M 40.37M 39.44M 39.51M 39.74M 39.76M 39.77M
Weighted Average Basic & Diluted Shares Outstanding
41.13M 41.00M 41.01M 40.55M 40.72M 40.37M 39.44M 39.51M 39.74M 39.76M 39.77M

Annual Cash Flow Statements for Sylvamo

This table details how cash moves in and out of Sylvamo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-40 -40 89 201 -80 -75 -70
Net Cash From Operating Activities
524 359 549 438 504 469 268
Net Cash From Continuing Operating Activities
524 245 423 418 504 469 268
Net Income / (Loss) Continuing Operations
377 87 227 336 253 302 132
Consolidated Net Income / (Loss)
377 - - - 253 302 132
Depreciation Expense
192 135 126 125 143 159 179
Non-Cash Adjustments To Reconcile Net Income
19 36 14 41 23 23 29
Changes in Operating Assets and Liabilities, net
-64 -11 56 -63 85 -15 -72
Net Cash From Investing Activities
-160 -79 127 180 -377 -221 -224
Net Cash From Continuing Investing Activities
-160 -68 113 185 -377 -221 -224
Purchase of Property, Plant & Equipment
-118 -66 -69 -149 -210 -221 -224
Acquisitions
- - 0.00 0.00 -167 0.00 0.00
Net Cash From Financing Activities
-387 -350 -589 -470 -219 -310 -125
Net Cash From Continuing Financing Activities
-387 -350 -588 -469 -219 -310 -125
Repayment of Debt
-18 -10 -113 -454 -538 -429 -199
Repurchase of Common Equity
- 0.00 0.00 -80 -70 -69 -82
Payment of Dividends
- 0.00 0.00 -10 -57 -62 -73
Issuance of Debt
0.00 0.00 1,501 75 446 250 229
Effect of Exchange Rate Changes
-17 30 -2.00 32 12 -13 11

Quarterly Cash Flow Statements for Sylvamo

This table details how cash moves in and out of Sylvamo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-71 -4.00 103 -103 -51 -41 -19 41 -5.00 -7.00 19
Net Cash From Operating Activities
27 115 163 164 23 64 87 94 -10 38 64
Net Cash From Continuing Operating Activities
27 115 163 164 23 64 87 94 -10 38 113
Net Income / (Loss) Continuing Operations
43 83 95 81 27 15 57 33 -3.00 -11 131
Consolidated Net Income / (Loss)
43 83 95 - 27 15 57 33 -3.00 -11 131
Depreciation Expense
39 37 39 44 40 45 49 45 41 43 21
Non-Cash Adjustments To Reconcile Net Income
7.00 5.00 5.00 6.00 6.00 7.00 4.00 12 -16 2.00 5.00
Changes in Operating Assets and Liabilities, net
-62 -10 24 33 -50 -3.00 -23 4.00 -32 4.00 -44
Net Cash From Investing Activities
-60 -53 -44 -64 -48 -66 -54 -56 -49 -60 -58
Net Cash From Continuing Investing Activities
-60 -53 -44 -64 -48 -66 -54 -56 -49 -60 -46
Purchase of Property, Plant & Equipment
-60 -53 -44 -64 -48 -66 -54 -56 -49 -61 -46
Net Cash From Financing Activities
-35 -60 -19 -196 -31 -45 -52 3.00 53 15 8.00
Net Cash From Continuing Financing Activities
-35 -60 -19 -196 -31 -45 -52 3.00 53 15 9.00
Repayment of Debt
-24 -32 -235 -138 -16 -32 -10 -141 -43 -424 -63
Payment of Dividends
-12 -13 -18 -19 -18 -18 -19 -18 -18 -18 -18
Issuance of Debt
6.00 10 234 - 23 25 19 162 114 457 90
Effect of Exchange Rate Changes
-3.00 -6.00 3.00 -7.00 5.00 6.00 - - 1.00 - -1.00

Annual Balance Sheets for Sylvamo

This table presents Sylvamo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
2,911 2,597 2,710 2,872 2,604 2,761
Total Current Assets
1,119 1,108 1,243 1,193 1,063 1,076
Cash & Equivalents
95 159 360 220 205 86
Note & Lease Receivable
621 402 450 428 429 348
Inventories, net
342 279 364 404 361 261
Other Current Assets
61 89 69 81 68 92
Other Current Nonoperating Assets
- 179 - - - 289
Plant, Property, & Equipment, net
0.00 0.00 817 0.00 0.00 0.00
Total Noncurrent Assets
1,792 1,489 650 1,679 1,541 1,685
Goodwill
143 122 128 139 111 114
Other Noncurrent Operating Assets
1,649 1,226 522 1,540 1,430 1,334
Other Noncurrent Nonoperating Assets
- 141 - - - 237
Total Liabilities & Shareholders' Equity
2,911 2,597 2,710 2,872 2,604 2,761
Total Liabilities
799 2,415 2,032 1,971 1,757 1,795
Total Current Liabilities
490 758 728 695 682 716
Short-Term Debt
4.00 41 29 28 22 88
Accounts Payable
284 387 453 421 375 267
Current Employee Benefit Liabilities
68 48 81 63 79 38
Other Current Liabilities
134 191 165 183 206 152
Other Current Nonoperating Liabilities
- 91 - - - 171
Total Noncurrent Liabilities
309 1,657 1,304 1,276 1,075 1,079
Long-Term Debt
22 1,357 1,003 931 782 758
Noncurrent Deferred & Payable Income Tax Liabilities
170 169 183 189 152 174
Other Noncurrent Operating Liabilities
117 118 118 156 141 125
Other Noncurrent Nonoperating Liabilities
- 13 - - - 22
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,112 182 678 901 847 966
Total Preferred & Common Equity
2,112 182 678 901 847 966
Total Common Equity
2,112 182 678 901 847 966
Common Stock
0.00 48 69 93 116 135
Retained Earnings
0.00 1,935 2,029 2,222 2,455 2,514
Treasury Stock
- 0.00 -82 - -234 -330
Accumulated Other Comprehensive Income / (Loss)
-1,480 -1,801 -1,338 -1,256 -1,490 -1,353

Quarterly Balance Sheets for Sylvamo

This table presents Sylvamo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
2,823 2,785 2,797 2,691 2,861 2,629 2,668 2,703 2,834 2,875 2,951
Total Current Assets
1,161 1,186 1,115 1,100 1,229 1,011 977 990 1,097 1,107 1,379
Cash & Equivalents
164 194 149 145 248 154 113 94 130 123 93
Note & Lease Receivable
440 423 413 411 439 416 383 393 378 366 303
Inventories, net
486 456 407 412 421 372 396 434 483 503 369
Other Current Assets
71 53 86 72 61 69 85 69 106 115 112
Other Current Nonoperating Assets
- - - - - - - - - - 502
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets
1,662 1,599 1,682 1,591 1,632 1,618 1,691 1,713 1,737 1,768 1,572
Goodwill
140 134 134 121 125 119 126 128 121 121 121
Other Noncurrent Operating Assets
1,522 1,465 1,548 1,470 1,507 1,499 1,565 1,585 1,616 1,647 1,451
Other Noncurrent Nonoperating Assets
- - - - - - - - - - 0.00
Total Liabilities & Shareholders' Equity
2,823 2,785 2,797 2,691 2,861 2,629 2,668 2,703 2,834 2,875 2,951
Total Liabilities
1,961 1,949 1,908 1,861 1,924 1,721 1,709 1,726 1,855 1,920 2,211
Total Current Liabilities
667 674 649 654 714 616 635 653 758 752 1,065
Short-Term Debt
79 53 28 28 43 23 46 30 155 121 139
Accounts Payable
391 382 404 389 381 386 371 383 407 422 283
Current Employee Benefit Liabilities
50 66 52 65 76 52 53 57 56 52 51
Other Current Liabilities
147 173 165 172 214 155 165 183 140 157 138
Other Current Nonoperating Liabilities
- - - - - - - - - - 454
Total Noncurrent Liabilities
1,294 1,275 1,259 1,207 1,210 1,105 1,074 1,073 1,097 1,168 1,146
Long-Term Debt
954 946 921 894 883 794 767 778 766 843 861
Noncurrent Deferred & Payable Income Tax Liabilities
212 202 180 162 164 162 151 148 179 171 148
Other Noncurrent Operating Liabilities
128 127 158 151 163 149 156 147 152 154 137
Other Noncurrent Nonoperating Liabilities
- - - - - - - - - - 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
862 836 889 830 937 908 959 977 979 955 740
Total Preferred & Common Equity
862 836 889 830 937 908 959 977 979 955 740
Total Common Equity
862 836 889 830 937 908 959 977 979 955 740
Common Stock
84 90 99 105 110 123 130 134 139 143 148
Retained Earnings
2,153 2,185 2,253 2,317 2,393 2,463 2,460 2,499 2,493 2,464 2,247
Treasury Stock
- -141 -170 -195 -195 -268 -288 -330 -336 - -336
Accumulated Other Comprehensive Income / (Loss)
-1,248 -1,298 -1,293 -1,397 -1,371 -1,410 -1,343 -1,326 -1,317 -1,316 -1,319

Annual Metrics And Ratios for Sylvamo

This table displays calculated financial ratios and metrics derived from Sylvamo's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - -
Revenue Growth
0.00% -40.63% 18.57% 28.29% 2.56% 1.40% -11.18%
EBITDA Growth
0.00% -67.01% 100.44% 45.92% -17.40% 10.44% -30.85%
EBIT Growth
0.00% -81.54% 259.34% 63.91% -24.81% 10.17% -46.40%
NOPAT Growth
0.00% -77.49% 171.56% 70.41% -28.35% 19.82% -52.32%
Net Income Growth
0.00% -54.91% 94.71% -64.35% 114.41% 19.37% -56.29%
EPS Growth
0.00% -54.97% 95.58% -64.67% 122.93% 21.08% -54.87%
Operating Cash Flow Growth
0.00% -31.49% 52.92% -20.22% 15.07% -6.94% -42.86%
Free Cash Flow Firm Growth
0.00% 0.00% 154.31% -77.39% -80.76% 904.24% -117.23%
Invested Capital Growth
0.00% 0.00% -41.02% 12.03% 17.04% -8.48% 16.46%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 15.25% 1.00% 0.16% -2.33%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 29.35% -9.75% 7.10% -8.15%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 34.34% -14.07% 8.29% -13.77%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 44.54% -14.45% 11.26% -23.42%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 37.21% -15.10% 11.85% -26.67%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% -13.81% 11.49% -25.35%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 7.02% -6.01% 5.22% -0.64% -20.71%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 103.68% 43.73% -214.24%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% -0.06% -7.01% -0.41%
Profitability Metrics
- - - - - - -
Gross Margin
34.33% 19.12% 24.22% 27.81% 24.51% 24.91% 21.93%
EBITDA Margin
17.05% 9.48% 16.02% 18.22% 14.67% 15.98% 12.44%
Operating Margin
12.27% 3.82% 11.56% 14.77% 10.83% 11.77% 7.10%
EBIT Margin
12.27% 3.82% 11.56% 14.77% 10.83% 11.77% 7.10%
Profit (Net Income) Margin
9.39% 7.13% 11.70% 3.25% 6.80% 8.00% 3.94%
Tax Burden Percent
75.10% 178.95% 100.91% 25.27% 68.56% 74.57% 66.33%
Interest Burden Percent
101.83% 104.40% 100.31% 87.13% 91.56% 91.22% 83.61%
Effective Tax Rate
24.90% 8.42% 30.79% 28.05% 31.44% 25.43% 33.67%
Return on Invested Capital (ROIC)
0.00% 8.16% 13.94% 30.19% 18.86% 21.88% 10.09%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -243.04% 35.88% -1.39% 15.41% 17.33% 6.16%
Return on Net Nonoperating Assets (RNNOA)
0.00% 7.94% 14.92% -2.75% 13.18% 12.67% 4.47%
Return on Equity (ROE)
0.00% 16.10% 28.86% 27.44% 32.05% 34.55% 14.56%
Cash Return on Invested Capital (CROIC)
0.00% -191.84% 65.54% 18.84% 3.16% 30.74% -5.12%
Operating Return on Assets (OROA)
0.00% 3.13% 11.87% 20.20% 14.44% 16.22% 8.87%
Return on Assets (ROA)
0.00% 5.84% 12.02% 4.45% 9.06% 11.03% 4.92%
Return on Common Equity (ROCE)
0.00% 16.10% 28.86% 27.44% 32.05% 34.55% 14.56%
Return on Equity Simple (ROE_SIMPLE)
0.00% 8.05% 181.87% 17.40% 28.08% 35.66% 0.00%
Net Operating Profit after Tax (NOPAT)
370 83 226 386 276 331 158
NOPAT Margin
9.22% 3.49% 8.00% 10.63% 7.43% 8.78% 4.71%
Net Nonoperating Expense Percent (NNEP)
0.00% 251.20% -21.95% 31.58% 3.45% 4.55% 3.93%
Return On Investment Capital (ROIC_SIMPLE)
- - - 22.55% 14.86% 20.05% 8.68%
Cost of Revenue to Revenue
65.67% 80.88% 75.78% 72.19% 75.49% 75.09% 78.07%
SG&A Expenses to Revenue
16.31% 8.47% 7.32% 8.96% 9.22% 8.24% 8.39%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
22.06% 15.30% 12.66% 13.04% 13.68% 13.15% 14.83%
Earnings before Interest and Taxes (EBIT)
493 91 327 536 403 444 238
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
685 226 453 661 546 603 417
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 0.00 6.40 2.98 2.20 3.80 1.95
Price to Tangible Book Value (P/TBV)
0.00 0.00 19.42 3.67 2.60 4.38 2.21
Price to Revenue (P/Rev)
0.00 0.00 0.41 0.56 0.53 0.85 0.56
Price to Earnings (P/E)
0.00 0.00 3.52 17.12 7.84 10.67 14.25
Dividend Yield
0.00% 0.00% 0.00% 0.49% 2.20% 1.91% 3.77%
Earnings Yield
0.00% 0.00% 28.41% 5.84% 12.76% 9.37% 7.02%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 2.00 1.99 1.68 2.64 1.54
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.85 0.74 0.72 1.01 0.78
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 5.31 4.07 4.87 6.34 6.23
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 7.35 5.02 6.60 8.61 10.92
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 10.62 6.98 9.63 11.54 16.46
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 4.38 6.15 5.28 8.15 9.70
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 2.26 11.19 57.47 8.22 0.00
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 0.01 7.68 1.52 1.06 0.95 0.88
Long-Term Debt to Equity
0.00 0.01 7.46 1.48 1.03 0.92 0.79
Financial Leverage
0.00 -0.03 0.42 1.97 0.86 0.73 0.73
Leverage Ratio
0.00 1.38 2.40 6.17 3.54 3.13 2.96
Compound Leverage Factor
0.00 1.44 2.41 5.38 3.24 2.86 2.48
Debt to Total Capital
0.00% 1.22% 88.48% 60.35% 51.56% 48.70% 46.89%
Short-Term Debt to Total Capital
0.00% 0.19% 2.59% 1.70% 1.51% 1.33% 4.95%
Long-Term Debt to Total Capital
0.00% 1.03% 85.89% 58.66% 50.05% 47.37% 41.95%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 98.78% 11.52% 39.65% 48.44% 51.30% 53.11%
Debt to EBITDA
0.00 0.12 3.09 1.56 1.76 1.33 2.05
Net Debt to EBITDA
0.00 -0.31 2.74 1.02 1.24 0.99 1.72
Long-Term Debt to EBITDA
0.00 0.10 3.00 1.52 1.71 1.30 1.83
Debt to NOPAT
0.00 0.31 6.18 2.68 3.47 2.43 5.40
Net Debt to NOPAT
0.00 -0.83 5.47 1.74 2.46 1.81 4.55
Long-Term Debt to NOPAT
0.00 0.26 6.00 2.60 3.37 2.36 4.83
Altman Z-Score
0.00 0.00 3.00 3.86 3.65 4.61 3.56
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - -
Current Ratio
0.00 2.28 1.46 1.71 1.72 1.56 1.50
Quick Ratio
0.00 1.46 0.74 1.11 0.93 0.93 0.78
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -1,960 1,064 241 46 465 -80
Operating Cash Flow to CapEx
455.65% 543.94% 795.65% 293.96% 240.00% 212.22% 119.64%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 3.49 1.36 11.93 -2.05
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 6.35 14.82 12.03 6.87
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 4.19 8.65 6.36 1.13
Efficiency Ratios
- - - - - - -
Asset Turnover
0.00 0.82 1.03 1.37 1.33 1.38 1.25
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 5.64 6.90 8.15 7.32 7.41 6.72
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 6.79 6.39 6.24 6.43 7.12 6.92
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 64.71 52.89 44.81 49.90 49.28 54.35
Days Payable Outstanding (DPO)
0.00 53.74 57.14 58.53 56.78 51.28 52.74
Cash Conversion Cycle (CCC)
0.00 10.97 -4.26 -13.73 -6.89 -2.00 1.60
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.00 2,043 1,205 1,350 1,580 1,446 1,684
Invested Capital Turnover
0.00 2.33 1.74 2.84 2.54 2.49 2.14
Increase / (Decrease) in Invested Capital
0.00 2,043 -838 145 230 -134 238
Enterprise Value (EV)
0.00 0.00 2,404 2,692 2,661 3,821 2,599
Market Capitalization
0.00 0.00 1,165 2,020 1,982 3,222 1,881
Book Value per Share
$0.00 $0.00 $4.13 $15.36 $21.68 $20.65 $24.49
Tangible Book Value per Share
$0.00 $0.00 $1.36 $12.46 $18.34 $17.95 $21.60
Total Capital
0.00 2,138 1,580 1,710 1,860 1,651 1,819
Total Debt
0.00 26 1,398 1,032 959 804 853
Total Long-Term Debt
0.00 22 1,357 1,003 931 782 763
Net Debt
0.00 -69 1,239 672 679 599 718
Capital Expenditures (CapEx)
115 66 69 149 210 221 224
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 538 232 184 246 198 315
Debt-free Net Working Capital (DFNWC)
0.00 633 391 544 526 403 450
Net Working Capital (NWC)
0.00 629 350 515 498 381 360
Net Nonoperating Expense (NNE)
-6.76 -87 -105 268 23 29 26
Net Nonoperating Obligations (NNO)
0.00 -69 1,023 672 679 599 718
Total Depreciation and Amortization (D&A)
192 135 126 125 143 159 179
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 22.56% 8.20% 5.07% 6.61% 5.25% 9.40%
Debt-free Net Working Capital to Revenue
0.00% 26.54% 13.83% 14.99% 14.14% 10.68% 13.43%
Net Working Capital to Revenue
0.00% 26.37% 12.38% 14.20% 13.38% 10.10% 10.74%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $7.53 $2.68 $6.02 $7.35 $3.29
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 43.96M 42.37M 41.22M 40.55M 39.51M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $7.53 $2.66 $5.93 $7.18 $3.24
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 43.96M 42.37M 41.22M 40.55M 39.51M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 43.96M 42.37M 41.22M 40.55M 39.51M
Normalized Net Operating Profit after Tax (NOPAT)
375 83 226 386 276 331 165
Normalized NOPAT Margin
9.33% 3.49% 8.00% 10.63% 7.43% 8.78% 4.93%
Pre Tax Income Margin
12.50% 3.98% 11.60% 12.87% 9.92% 10.73% 5.94%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 7.77 11.85 11.38 6.10
NOPAT to Interest Expense
0.00 0.00 0.00 5.59 8.13 8.49 4.05
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 5.61 5.68 5.72 0.36
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 3.43 1.95 2.82 -1.70
Payout Ratios
- - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 8.47% 22.53% 20.53% 55.30%
Augmented Payout Ratio
0.00% 0.00% 0.00% 76.27% 50.20% 43.38% 117.42%

Quarterly Metrics And Ratios for Sylvamo

This table displays calculated financial ratios and metrics derived from Sylvamo's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 39,508,287.00 39,736,136.00 39,760,243.00
DEI Adjusted Shares Outstanding
- - - - - - - - 39,508,287.00 39,736,136.00 39,760,243.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - -0.08 -0.28 -5.01
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-3.83% 1.52% 7.58% 0.62% -9.28% -14.90% -12.33% -8.25% -8.04% 1.51% -2.57%
EBITDA Growth
-40.98% 37.07% 36.03% 36.04% -24.07% -52.83% -21.08% -24.50% -46.34% -26.67% -24.82%
EBIT Growth
-53.38% 48.78% 46.00% 46.58% -39.13% -75.41% -33.56% -35.51% -92.86% -60.00% -26.79%
NOPAT Growth
-51.43% 56.12% 64.86% 62.34% -30.51% -74.89% -40.21% -54.70% -93.89% -686.67% 29.62%
Net Income Growth
-55.67% 69.39% 63.79% 65.31% -37.21% -81.93% -40.00% -59.26% -111.11% -173.33% -449.12%
EPS Growth
-54.67% 73.68% 65.69% 63.25% -36.27% -81.31% -37.89% -57.59% -112.31% -175.68% -453.19%
Operating Cash Flow Growth
-57.14% 49.35% -17.26% -1.80% -14.81% -44.35% -46.63% -42.68% -143.48% -40.63% -26.44%
Free Cash Flow Firm Growth
188.83% 182.26% 108.64% 224.95% 19.26% -132.71% -155.82% -190.06% -313.18% -200.56% 415.55%
Invested Capital Growth
-1.69% -10.63% -1.64% -8.48% -3.56% 7.24% 8.75% 16.46% 12.67% 8.26% -5.44%
Revenue Q/Q Growth
-6.12% 3.09% 3.43% 0.52% -15.36% -3.29% 6.55% 5.20% -15.17% 6.76% -19.98%
EBITDA Q/Q Growth
-2.70% 47.22% 16.35% -18.38% -45.70% -8.54% 94.67% -21.92% -61.40% 25.00% 87.27%
EBIT Q/Q Growth
-5.48% 76.81% 19.67% -26.71% -60.75% -28.57% 223.33% -28.87% -95.65% 300.00% 583.33%
NOPAT Q/Q Growth
-7.38% 81.21% 17.26% -17.52% -60.35% -34.52% 179.24% -37.52% -94.65% -6,385.71% 174.37%
Net Income Q/Q Growth
-12.24% 93.02% 14.46% -14.74% -66.67% -44.44% 280.00% -42.11% -109.09% -266.67% -1,709.09%
EPS Q/Q Growth
-12.82% 94.12% 14.65% -15.86% -65.97% -43.08% 281.08% -42.55% -109.88% -250.00% -1,678.57%
Operating Cash Flow Q/Q Growth
-83.83% 325.93% 41.74% 0.61% -85.98% 178.26% 35.94% 8.05% -110.64% 480.00% 68.42%
Free Cash Flow Firm Q/Q Growth
143.85% 253.27% -52.09% 68.35% -58.14% -196.90% 18.25% -171.61% 0.93% -36.62% 170.69%
Invested Capital Q/Q Growth
3.10% -5.03% 0.52% -7.01% 8.64% 5.60% 1.93% -0.41% 5.11% 1.47% -10.97%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
20.88% 26.69% 27.46% 24.43% 19.37% 19.40% 26.24% 22.47% 16.56% 16.38% 31.78%
EBITDA Margin
11.93% 17.04% 19.17% 15.57% 9.99% 9.45% 17.26% 12.81% 5.83% 6.82% 15.97%
Operating Margin
7.62% 13.08% 15.13% 11.03% 5.12% 3.78% 11.47% 7.75% 0.40% 1.49% 12.71%
EBIT Margin
7.62% 13.08% 15.13% 11.03% 5.12% 3.78% 11.47% 7.75% 0.40% 1.49% 12.71%
Profit (Net Income) Margin
4.75% 8.90% 9.84% 8.35% 3.29% 1.89% 6.74% 3.71% -0.40% -1.36% -30.85%
Tax Burden Percent
71.67% 73.45% 71.97% 81.00% 81.82% 75.00% 64.77% 56.90% 50.00% -1,100.00% -280.28%
Interest Burden Percent
86.96% 92.62% 90.41% 93.46% 78.57% 66.67% 90.72% 84.06% -200.00% 8.33% 86.59%
Effective Tax Rate
28.33% 26.55% 28.03% 19.00% 18.18% 25.00% 35.23% 43.10% 0.00% 1,200.00% -19.72%
Return on Invested Capital (ROIC)
12.26% 21.68% 26.16% 22.28% 9.65% 6.28% 15.70% 9.45% 0.55% -31.26% 30.35%
ROIC Less NNEP Spread (ROIC-NNEP)
11.45% 20.84% 24.68% 21.39% 8.60% 5.22% 14.82% 8.49% -0.15% -15.55% -7.44%
Return on Net Nonoperating Assets (RNNOA)
10.96% 19.54% 18.97% 15.64% 6.71% 4.13% 10.32% 6.17% -0.12% -12.52% -6.81%
Return on Equity (ROE)
23.22% 41.21% 45.13% 37.92% 16.37% 10.41% 26.02% 15.62% 0.43% -43.78% 23.53%
Cash Return on Invested Capital (CROIC)
15.33% 26.86% 20.64% 30.74% 23.34% 8.52% 4.32% -5.12% -4.32% -2.28% 13.31%
Operating Return on Assets (OROA)
10.04% 17.54% 20.19% 15.20% 6.96% 5.01% 14.14% 9.68% 0.48% 1.77% 14.75%
Return on Assets (ROA)
6.26% 11.94% 13.14% 11.51% 4.47% 2.50% 8.31% 4.63% -0.48% -1.62% -35.80%
Return on Common Equity (ROCE)
23.22% 41.21% 45.13% 37.92% 16.37% 10.41% 26.02% 15.62% 0.43% -43.78% 23.53%
Return on Equity Simple (ROE_SIMPLE)
22.38% 28.07% 28.82% 0.00% 31.50% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
49 90 105 87 34 23 63 39 2.10 -132 98
NOPAT Margin
5.46% 9.60% 10.89% 8.94% 4.19% 2.83% 7.43% 4.41% 0.28% -16.38% 15.22%
Net Nonoperating Expense Percent (NNEP)
0.80% 0.83% 1.48% 0.89% 1.05% 1.06% 0.88% 0.95% 0.70% -15.70% 37.78%
Return On Investment Capital (ROIC_SIMPLE)
- - - 5.25% 1.99% 1.27% 3.52% 2.16% 0.11% -6.88% 5.64%
Cost of Revenue to Revenue
79.12% 73.31% 72.54% 75.57% 80.63% 80.60% 73.76% 77.53% 83.44% 83.62% 68.22%
SG&A Expenses to Revenue
8.18% 8.79% 7.67% 8.35% 8.89% 9.07% 8.04% 7.64% 9.67% 8.56% 12.71%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
13.26% 13.61% 12.33% 13.40% 14.25% 15.62% 14.78% 14.72% 16.16% 14.89% 19.07%
Earnings before Interest and Taxes (EBIT)
69 122 146 107 42 30 97 69 3.00 12 82
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
108 159 185 151 82 75 146 114 44 55 103
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.85 3.38 3.74 3.80 2.97 2.11 1.81 1.95 1.69 1.55 1.73
Price to Tangible Book Value (P/TBV)
3.36 3.95 4.31 4.38 3.42 2.43 2.08 2.21 1.92 1.78 2.07
Price to Revenue (P/Rev)
0.69 0.76 0.93 0.85 0.73 0.57 0.52 0.56 0.50 0.45 0.39
Price to Earnings (P/E)
12.74 12.03 12.97 10.67 9.44 9.28 9.82 14.25 16.19 19.54 0.00
Dividend Yield
1.80% 1.69% 1.58% 1.91% 2.48% 3.62% 4.11% 3.77% 4.31% 4.82% 5.58%
Earnings Yield
7.85% 8.31% 7.71% 9.37% 10.60% 10.78% 10.18% 7.02% 6.18% 5.12% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.01 2.27 2.65 2.64 2.14 1.64 1.47 1.54 1.38 1.30 1.37
Enterprise Value to Revenue (EV/Rev)
0.89 0.95 1.09 1.01 0.91 0.77 0.72 0.78 0.74 0.71 0.67
Enterprise Value to EBITDA (EV/EBITDA)
6.95 6.85 7.32 6.34 5.83 5.52 5.47 6.23 6.44 6.48 6.73
Enterprise Value to EBIT (EV/EBIT)
10.11 9.67 10.05 8.61 8.06 8.38 8.99 10.92 12.27 12.85 14.49
Enterprise Value to NOPAT (EV/NOPAT)
14.63 13.73 13.84 11.54 10.65 10.95 12.04 16.46 19.25 23.84 17.23
Enterprise Value to Operating Cash Flow (EV/OCF)
7.00 6.95 8.73 8.15 7.23 6.58 7.34 9.70 10.39 11.13 11.77
Enterprise Value to Free Cash Flow (EV/FCFF)
13.00 7.99 12.73 8.22 9.00 19.93 35.38 0.00 0.00 0.00 9.99
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.07 1.11 0.99 0.95 0.90 0.85 0.83 0.88 0.94 1.01 1.35
Long-Term Debt to Equity
1.04 1.08 0.94 0.92 0.87 0.80 0.80 0.79 0.78 0.88 1.16
Financial Leverage
0.96 0.94 0.77 0.73 0.78 0.79 0.70 0.73 0.77 0.81 0.92
Leverage Ratio
3.33 3.26 3.18 3.13 3.02 3.00 2.91 2.96 2.90 2.90 3.29
Compound Leverage Factor
2.90 3.02 2.88 2.93 2.37 2.00 2.64 2.49 -5.79 0.24 2.85
Debt to Total Capital
51.63% 52.63% 49.70% 48.70% 47.36% 45.88% 45.27% 46.89% 48.47% 50.23% 57.47%
Short-Term Debt to Total Capital
1.52% 1.60% 2.31% 1.33% 1.33% 2.60% 1.68% 4.95% 8.16% 6.31% 7.99%
Long-Term Debt to Total Capital
50.11% 51.03% 47.40% 47.37% 46.03% 43.28% 43.59% 41.95% 40.32% 43.93% 49.48%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
48.37% 47.37% 50.30% 51.30% 52.64% 54.12% 54.73% 53.11% 51.53% 49.77% 42.53%
Debt to EBITDA
2.01 1.79 1.64 1.33 1.42 1.65 1.78 2.05 2.43 2.69 3.08
Net Debt to EBITDA
1.57 1.39 1.10 0.99 1.15 1.42 1.57 1.72 2.09 2.34 2.79
Long-Term Debt to EBITDA
1.96 1.74 1.57 1.30 1.38 1.56 1.71 1.83 2.02 2.35 2.65
Debt to NOPAT
4.24 3.60 3.11 2.43 2.59 3.27 3.92 5.40 7.26 9.88 7.87
Net Debt to NOPAT
3.31 2.80 2.08 1.81 2.10 2.82 3.46 4.55 6.24 8.62 7.14
Long-Term Debt to NOPAT
4.11 3.49 2.97 2.36 2.52 3.09 3.77 4.83 6.04 8.64 6.78
Altman Z-Score
3.52 3.83 3.96 4.18 3.89 3.52 3.45 3.35 3.07 2.97 2.74
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.72 1.68 1.72 1.56 1.64 1.54 1.52 1.50 1.45 1.47 1.29
Quick Ratio
0.87 0.85 0.96 0.93 0.93 0.78 0.75 0.78 0.67 0.65 0.37
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
77 274 131 221 92 -90 -73 -199 -197 -269 190
Operating Cash Flow to CapEx
45.00% 216.98% 370.45% 256.25% 47.92% 96.97% 161.11% 167.86% -20.41% 62.30% 139.13%
Free Cash Flow to Firm to Interest Expense
8.61 30.40 9.36 31.52 10.26 -8.95 -8.13 -18.07 -21.88 -24.45 17.29
Operating Cash Flow to Interest Expense
3.00 12.78 11.64 23.43 2.56 6.40 9.67 8.55 -1.11 3.45 5.82
Operating Cash Flow Less CapEx to Interest Expense
-3.67 6.89 8.50 14.29 -2.78 -0.20 3.67 3.45 -6.56 -2.09 1.64
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.32 1.34 1.33 1.38 1.36 1.32 1.23 1.25 1.20 1.19 1.16
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
6.25 6.28 6.51 7.41 7.13 6.77 6.22 6.72 6.04 5.82 6.51
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
7.02 7.23 7.48 7.12 7.04 7.20 6.96 6.92 6.52 6.60 7.85
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
58.36 58.16 56.10 49.28 51.16 53.92 58.68 54.35 60.39 62.67 56.04
Days Payable Outstanding (DPO)
51.97 50.51 48.81 51.28 51.88 50.71 52.44 52.74 56.01 55.28 46.48
Cash Conversion Cycle (CCC)
6.39 7.64 7.29 -2.00 -0.72 3.20 6.25 1.60 4.38 7.39 9.56
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,629 1,547 1,555 1,446 1,571 1,659 1,691 1,684 1,770 1,796 1,599
Invested Capital Turnover
2.24 2.26 2.40 2.49 2.31 2.21 2.11 2.14 1.97 1.91 1.99
Increase / (Decrease) in Invested Capital
-28 -184 -26 -134 -58 112 136 238 199 137 -92
Enterprise Value (EV)
3,276 3,519 4,119 3,821 3,361 2,722 2,481 2,599 2,442 2,326 2,189
Market Capitalization
2,536 2,802 3,501 3,222 2,698 2,022 1,767 1,881 1,651 1,485 1,282
Book Value per Share
$21.62 $20.18 $22.85 $20.65 $22.39 $23.55 $24.20 $24.49 $24.78 $24.03 $18.61
Tangible Book Value per Share
$18.36 $17.24 $19.80 $17.95 $19.46 $20.46 $21.03 $21.60 $21.72 $20.99 $15.57
Total Capital
1,838 1,752 1,863 1,651 1,725 1,772 1,785 1,819 1,900 1,919 1,740
Total Debt
949 922 926 804 817 813 808 853 921 964 1,000
Total Long-Term Debt
921 894 883 782 794 767 778 763 766 843 861
Net Debt
740 717 618 599 663 700 714 718 791 841 907
Capital Expenditures (CapEx)
60 53 44 64 48 66 54 56 49 61 46
Debt-free, Cash-free Net Working Capital (DFCFNWC)
285 269 250 198 264 275 273 315 364 353 360
Debt-free Net Working Capital (DFNWC)
494 474 558 403 418 388 367 450 494 476 453
Net Working Capital (NWC)
466 446 515 381 395 342 337 360 339 355 314
Net Nonoperating Expense (NNE)
6.45 6.61 10 5.67 7.36 7.50 5.83 6.26 5.10 -121 297
Net Nonoperating Obligations (NNO)
740 717 618 599 663 700 714 718 791 841 859
Total Depreciation and Amortization (D&A)
39 37 39 44 40 45 49 45 41 43 21
Debt-free, Cash-free Net Working Capital to Revenue
7.73% 7.27% 6.64% 5.25% 7.16% 7.75% 7.96% 9.40% 11.08% 10.71% 10.98%
Debt-free Net Working Capital to Revenue
13.41% 12.81% 14.81% 10.68% 11.33% 10.93% 10.70% 13.43% 15.04% 14.44% 13.81%
Net Working Capital to Revenue
12.65% 12.06% 13.67% 10.10% 10.71% 9.63% 9.82% 10.74% 10.32% 10.77% 9.57%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.04 $2.02 $2.32 $1.97 $0.66 $0.37 $1.43 $0.83 ($0.08) ($0.28) ($5.00)
Adjusted Weighted Average Basic Shares Outstanding
41.13M 41.00M 41.01M 40.55M 40.72M 40.37M 39.44M 39.51M 39.74M 39.76M 39.77M
Adjusted Diluted Earnings per Share
$1.02 $1.98 $2.27 $1.91 $0.65 $0.37 $1.41 $0.81 ($0.08) ($0.28) ($4.98)
Adjusted Weighted Average Diluted Shares Outstanding
41.13M 41.00M 41.01M 40.55M 40.72M 40.37M 39.44M 39.51M 39.74M 39.76M 39.77M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
41.13M 41.00M 41.01M 40.55M 40.72M 40.37M 39.44M 39.51M 39.74M 39.76M 39.77M
Normalized Net Operating Profit after Tax (NOPAT)
49 90 105 87 34 23 63 39 2.10 8.40 57
Normalized NOPAT Margin
5.46% 9.60% 10.89% 8.94% 4.19% 2.83% 7.43% 4.41% 0.28% 1.04% 8.90%
Pre Tax Income Margin
6.63% 12.11% 13.68% 10.31% 4.02% 2.52% 10.40% 6.52% -0.79% 0.12% 11.01%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
7.67 13.56 10.43 15.29 4.67 3.00 10.78 6.27 0.33 1.09 7.45
NOPAT to Interest Expense
5.49 9.96 7.51 12.38 3.82 2.25 6.98 3.57 0.23 -12.00 8.92
EBIT Less CapEx to Interest Expense
1.00 7.67 7.29 6.14 -0.67 -3.60 4.78 1.18 -5.11 -4.45 3.27
NOPAT Less CapEx to Interest Expense
-1.17 4.07 4.36 3.24 -1.52 -4.35 0.98 -1.52 -5.21 -17.55 4.74
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
29.65% 26.18% 25.19% 20.53% 23.78% 33.49% 41.11% 55.30% 71.57% 96.05% -40.00%
Augmented Payout Ratio
62.31% 51.93% 42.59% 43.38% 53.15% 69.72% 108.33% 117.42% 132.35% 151.32% -40.00%

Financials Breakdown Chart

Key Financial Trends

Sylvamo’s Q2 2026 results show a modest sequential improvement in sales and operating profit, but the broader earnings trend remains weak. Revenue increased to $806 million from $755 million in Q1 2026 and was slightly above the restated $794 million reported in Q2 2025. Gross profit also rose sequentially to $132 million, while operating income improved from $3 million to $12 million. However, both figures remained well below Q2 2024 levels of $249 million and $122 million, respectively.

Profitability has deteriorated substantially over the past several years. Quarterly net income declined from $97 million in Q1 2023 and $83 million in Q2 2024 to $15 million in Q2 2025, followed by losses of $3 million in Q1 2026 and $11 million in Q2 2026. Q2 2026’s $0.28 loss per share was also a sharp reversal from earnings of $0.37 per share in the year-ago quarter. Higher interest expense, which increased to $11 million from $9 million in Q1 2026, further pressured pretax income.

Cash generation improved from Q1 2026, when operating cash flow was negative $10 million, to $38 million in Q2. Nevertheless, capital expenditures of $61 million exceeded operating cash flow, resulting in estimated negative free cash flow of approximately $22 million. Sylvamo also relied on significant debt refinancing activity, issuing $457 million of debt while repaying $424 million. Cash and equivalents declined to $123 million from $154 million at the end of Q1 2025, although current assets of $1.11 billion exceeded current liabilities of $752 million.

  • Sequential revenue recovery: Q2 2026 revenue increased 6.8% from Q1 2026 and was 1.5% above the restated Q2 2025 figure.
  • Operating performance improved from Q1: Gross profit rose to $132 million from $125 million, and operating income increased to $12 million from $3 million.
  • Operating cash flow returned to positive territory: Sylvamo generated $38 million from operations in Q2 2026, compared with negative $10 million in Q1.
  • Share count remains below prior-year levels: Weighted-average basic shares were approximately 39.8 million in Q2 2026, down from 40.4 million in Q2 2025 and 41.0 million in Q2 2024.
  • Liquidity remains adequate but has weakened: The current ratio was approximately 1.47 at June 30, 2026, but cash declined to $123 million from $130 million at the end of Q1 and $154 million at the end of Q1 2025.
  • Equity has held relatively steady: Total common equity was $955 million in Q2 2026, compared with $979 million in Q1 and $959 million in Q2 2025, despite the recent losses.
  • Multi-year earnings deterioration: Net income fell from $97 million in Q1 2023 and $83 million in Q2 2024 to a $11 million loss in Q2 2026.
  • Margins remain far below earlier levels: Q2 2026 gross margin was approximately 16.4%, versus 19.4% in Q2 2025, 26.7% in Q2 2024 and 21.5% in Q2 2023.
  • Free cash flow was negative: Q2 operating cash flow of $38 million did not cover $61 million of capital expenditures, producing an estimated $22 million cash shortfall before financing activity.
  • Leverage and refinancing dependence increased: Total debt rose to approximately $964 million in Q2 2026 from $921 million in Q1 and $813 million in Q2 2025, while the company issued $457 million and repaid $424 million of debt during the quarter.
11/20/26 02:36 AM ETAI Generated. May Contain Errors.

Sylvamo Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Sylvamo's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Sylvamo's net income appears to be on a downward trend, with a most recent value of $132 million in 2025, falling from $377 million in 2019. The previous period was $302 million in 2024. See Sylvamo's forecast for analyst expectations on what's next for the company.

Sylvamo's total operating income in 2025 was $238 million, based on the following breakdown:
  • Total Gross Profit: $735 million
  • Total Operating Expenses: $497 million

Over the last 6 years, Sylvamo's total revenue changed from $4.02 billion in 2019 to $3.35 billion in 2025, a change of -16.6%.

In the past 13 quarters, Sylvamo's cash and equivalents has ranged from $93 million in Q3 2026 to $248 million in Q3 2024, and is currently $93 million as of their latest financial filing in Q3 2026.

Sylvamo had total debt of $853 million at the end of 2025, a 6.1% increase from 2024, and none in 2019.

Over the last 6 years, Sylvamo's book value per share changed from 0.00 in 2019 to 24.49 in 2025, a change of 2,449.4%.



Financial statements for NYSE:SLVM last updated on 11/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners